0001209191-18-052558.txt : 20180928
0001209191-18-052558.hdr.sgml : 20180928
20180928162302
ACCESSION NUMBER: 0001209191-18-052558
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180926
FILED AS OF DATE: 20180928
DATE AS OF CHANGE: 20180928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EDWARDS JEFFREY L
CENTRAL INDEX KEY: 0001190642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37783
FILM NUMBER: 181094441
MAIL ADDRESS:
STREET 1: 2525 DUPONT DR
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clearside Biomedical, Inc.
CENTRAL INDEX KEY: 0001539029
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452437375
STATE OF INCORPORATION: GA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30005
BUSINESS PHONE: 678-270-3631
MAIL ADDRESS:
STREET 1: 900 NORTH POINT PARKWAY
STREET 2: SUITE 200
CITY: ALPHARETTA
STATE: 2Q
ZIP: 30005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-26
0
0001539029
Clearside Biomedical, Inc.
CLSD
0001190642
EDWARDS JEFFREY L
C/O CLEARSIDE BIOMEDICAL, INC.
900 NORTH POINT PARKWAY, SUITE 200
ALPHARETTA
GA
30005
1
0
0
0
Stock Option (right to buy)
6.03
2018-09-26
4
A
0
22500
0.00
A
2028-09-25
Common Stock
22500
22500
D
This option will vest and become exercisable in 36 equal monthly installments through September 26, 2021, subject to the reporting person's continuous service as of such vesting dates.
/s/ Mark Ballantyne, Attorney-in-Fact
2018-09-28